SCHEMBL8201347

SCHEMBL8201347

c1cc(C2=NCCN2)cc(-c2cccc3ccccc23)c1

nearest known ligand 0.72

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 15/20 0.72
MAOB P27338 2/20 0.52
ACHE P22303 1/20 0.48
MAOA P21397 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8197228 0.88 NISCH (0.77) NISCHMAOBMAOA
SCHEMBL9575177 0.84 NISCH (1.00) NISCH
SCHEMBL9189709 0.82 NISCH (0.85) NISCHMAOBACHE
SCHEMBL8186147 0.81 NISCH (0.87) NISCH
SCHEMBL11132092 0.79 NISCH (0.74) NISCHMAOBMAOA
SCHEMBL8199611 0.77 NISCH (0.63) NISCHMAOB
Hydrochloric Acid SCHEMBL7735465 0.77 NISCH (0.55) NISCH
SCHEMBL14036308 0.77 MCL1 (0.53)
SCHEMBL29628903 0.77 MCL1 (0.53)
Benazoline SCHEMBL9575180 0.74 NISCH (1.00) NISCH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed